Sanofi

News

Sanofi appoints its first chief digital officer

Sanofi has become the latest big pharma firm to appoint a chief digital officer, choosing Ameet Nathwani to take up the position, adding onto his current role of executive vice president, c

News

Pharma companies clear the R&D decks in Q4

The fourth-quarter results season has already seen a host of unwanted projects cleared from pharma companies' pipelines as they tighten their focus on the projects with the most chance of a

News

Sanofi expects growth as rare disease drugs boost earnings

Sanofi’s strategy of betting on new drugs and biotech acquisitions seems to be paying off, as the company has forecast growth for 2019 thanks to higher than expected quarterly earnings and

News

Sanofi's Darzalex rival hits the mark in phase 3 trial

Johnson & Johnson’s Darzalex multiple myeloma drug has just become a blockbuster – but it could face competition from a rival from Sanofi that has just checked out in a phase 3 trial.

News

NHS faces uphill battle in prevention – survey

A new survey has revealed confusion amongst the UK public on how to maintain a healthy lifestyle, suggesting the NHS has a long way to go to meet its goal of more disease prevention.

News

FDA advisers divided on Sanofi’s oral type 1 diabetes drug

The future of Sanofi and Lexicon’s oral diabetes drug Zynquista hangs in the balance after an FDA advisory committee was split on whether the drug would benefit patients.

Sanofi appoints its first chief digital officer

Pharma companies clear the R&D decks in Q4

Sanofi expects growth as rare disease drugs boost earnings

Sanofi's Darzalex rival hits the mark in phase 3 trial

NHS faces uphill battle in prevention – survey

FDA advisers divided on Sanofi’s oral type 1 diabetes drug

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Sanofi

Editor's Picks